{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:34:24Z","timestamp":1789893264777,"version":"4.0.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00636","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T04:29:35Z","timestamp":1553833775000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid"],"prefix":"10.3389","volume":"10","author":[{"given":"Pardis-Sadat","family":"Tabatabaei-Panah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Moravvej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Sadaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadis","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Geranmayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Hajmanouchehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sajjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Arghand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 is critical in the autoimmunity of bullous pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of Autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2302\/kjm.52.128","article-title":"Immunopathology of bullous pemphigoid, an autoimmune and inflammatory skin blistering disease","volume":"52","author":"Liu","year":"2003","journal-title":"Keio J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1586\/edm.09.23","article-title":"Expression of cytokines and chemokines in bullous pemphigoid","volume":"4","author":"Nakashima","year":"2014","journal-title":"Exp Rev Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2133.1998.02169.x","article-title":"Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity","volume":"138","author":"Ameglio","year":"1998","journal-title":"Br J Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0923-1811(97)00044-3","article-title":"Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid","volume":"16","author":"Inaoki","year":"1998","journal-title":"J Dermatol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/000155599750010689","article-title":"Blister fluid cytokines in cutaneous inflammatory bullous disorders","volume":"79","author":"Rhodes","year":"1999","journal-title":"Acta Derm Venereol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B13","first-page":"419","article-title":"Proinflammatory cytokines interleukin 1 and tumor necrosis factor induce cytokines that are chemotactic for neutrophils, T cells and monocytes","volume":"349","author":"Larsen","year":"1990","journal-title":"Prog Clin Biol Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4049\/jimmunol.181.1.669","article-title":"IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis","volume":"181","author":"Skov","year":"2008","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s10067-009-1238-4","article-title":"Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic macedonians","volume":"28","author":"Trajkov","year":"2009","journal-title":"Clin Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"98993","DOI":"10.18632\/oncotarget.20114","article-title":"Association between polymorphism within interleukin related genes and graves' disease: a meta-analysis of 22 case-control studies","volume":"8","author":"Tu","year":"2017","journal-title":"Oncotarget."},{"key":"B17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2133.2005.06938.x","article-title":"Cytokine gene polymorphisms in bullous pemphigoid in a chinese population","volume":"154","author":"Chang","year":"2006","journal-title":"Br J Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/HAB-180339","article-title":"TNF-alpha\u2212308G\/A gene polymorphism in bullous pemphigoid and alopecia areata","volume":"26","author":"Moravvej","year":"2018","journal-title":"Hum Antibodies."},{"key":"B19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the european dermatology forum consensus in collaboration with the european academy of dermatology and venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"302568","DOI":"10.1155\/2014\/302568","article-title":"genetic polymorphisms of interleukin-1 alpha and the vitamin d receptor in mexican mestizo patients with intervertebral disc degeneration","volume":"2014","author":"Cervin Serrano","year":"2014","journal-title":"Int J Genomics."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-015-0378-x","article-title":"Association between interleukin 8-251 T\/A and +781 C\/T polymorphisms and glioma risk","author":"Liu","year":"2015","journal-title":"Diagn Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1475-2875-4-38","article-title":"A functional polymorphism in the IL1B gene promoter, IL1B\u221231C>T, is not associated with cerebral malaria in Thailand","volume":"4","author":"Ohashi","year":"2005","journal-title":"Malaria J."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/hmg\/8.8.1443","article-title":"A common functional polymorphism (C\u2013>A substitution at position\u2212863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha","volume":"8","author":"Skoog","year":"1999","journal-title":"Hum Mol Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.archoralbio.2010.09.004","article-title":"Association of IL1 gene polymorphisms with chronic periodontitis in Brazilians","volume":"56","author":"Trevilatto","year":"2011","journal-title":"Arch Oral Biol."},{"key":"B25","first-page":"7","article-title":"Prevalence of the\u2212308 and\u2212238 tumor necrosis factor alpha (TNF-alpha) promoter polymorphisms in mexican chronic hepatitis C patients","volume":"75","author":"Trujillo-Murillo","year":"2010","journal-title":"Rev Gastroenterol Mex."},{"key":"B26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1042\/CS20020367","article-title":"Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction","volume":"105","author":"Akatsu","year":"2003","journal-title":"Clin Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim Biophys Acta."},{"key":"B28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000236686","article-title":"Role of interleukin-8 receptor in skin","volume":"104","author":"Kemeny","year":"1994","journal-title":"Int Arch Allergy Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cellsig.2009.01.005","article-title":"Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways","volume":"21","author":"Sanmiguel","year":"2009","journal-title":"Cell Signal."},{"key":"B30","first-page":"339","article-title":"Cytokines in autoimmune bullous skin diseases. epiphenomena or contribution to pathogenesis?","volume":"144","author":"Ludwig","year":"2009","journal-title":"G Ital Dermatol Venereol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4615-0171-8_1","article-title":"Cytokines and chemokines in autoimmune disease: an overview","volume":"520","author":"Santamaria","year":"2003","journal-title":"Adv Exp Med Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.4049\/jimmunol.1402688","article-title":"Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules","volume":"194","author":"Sadeghi","year":"2015","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2012.08.002","article-title":"Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction","volume":"40","author":"Samavedam","year":"2013","journal-title":"J Autoimmun"},{"key":"B34","first-page":"312","article-title":"Association of IL-8 (-251 a\/t) gene polymorphism with clinical parameters and chronic periodontitis","volume":"10","author":"Khosropanah","year":"2013","journal-title":"J Dent."},{"key":"B35","first-page":"427","article-title":"Evaluation of IL-8 gene polymorphisms in patients with periodontitis in Hamedan, Iran","volume":"9","author":"Houshmand","year":"2012","journal-title":"Dent Res J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/0971-5916.187107","article-title":"Interleukin-1beta (IL-1beta) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE","volume":"143","author":"Mohammadoo-Khorasani","year":"2016","journal-title":"Indian J Med Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1684\/ecn.2011.0293","article-title":"Association of IL1R polymorphism with HLA-B27 positive in Iranian patients with ankylosing spondylitis","volume":"22","author":"Mahmoudi","year":"2011","journal-title":"Eur Cytokine Netw."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00296-013-2784-2","article-title":"Interleukin-1 gene cluster and IL-1 receptor polymorphisms in iranian patients with systemic lupus erythematosus","volume":"33","author":"Tahmasebi","year":"2013","journal-title":"Rheumatol Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3346\/jkms.2017.32.1.33","article-title":"Polymorphisms of Promoter Region of TNF-alpha gene in iranian azeri turkish patients with behcet's disease","volume":"32","author":"Abdolmohammadi","year":"2017","journal-title":"J Korean Med Sci."},{"key":"B40","first-page":"1006","article-title":"Genetic association of TNF-alpha-308 G\/A and\u2212863 C\/A polymorphisms with late onset alzheimer's disease in azeri turk population of Iran","volume":"16","author":"Ardebili","year":"2011","journal-title":"J Res Med Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/1319-3767.126322","article-title":"TNF-alpha gene polymorphisms in iranian azari turkish patients with inflammatory bowel diseases","volume":"20","author":"Bonyadi","year":"2014","journal-title":"Saudi J Gastroenterol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5606\/ArchRheumatol.2016.5907","article-title":"Tumor necrosis factor alpha gene polymorphism and association with its serum level in iranian population with rheumatoid arthritis","volume":"31","author":"Hadinedoushan","year":"2016","journal-title":"Arch Rheumatol."},{"key":"B43","first-page":"137","article-title":"Pemphigus and pemphigoid epidermocytes interfere with interleukin cascade reactions","volume":"32","author":"Grando","year":"1990","journal-title":"J Clin Lab Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0923-1811(95)00435-1","article-title":"Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid","volume":"11","author":"Schmidt","year":"1996","journal-title":"J Dermatol Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1365-2133.1998.02341.x","article-title":"Bullous pemphigoid blisters of the same duration have similar cytokine concentrations which decrease in older blisters","volume":"139","author":"Giacalone","year":"1998","journal-title":"Br J Dermatol."},{"key":"B46","first-page":"538","article-title":"Interleukin-1 and\u22126 are required for subepidermal blistering in experimental bullous pemphigoid","volume":"4","author":"Liu","year":"1997","journal-title":"J Invest Dermatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1007\/s11033-010-0641-x","article-title":"Tumor necrosis factor-alpha: investigation of gene polymorphism and regulation of TACE-TNF-alpha system in patients with acute myocardial infarction","volume":"38","author":"Ghaderian","year":"2011","journal-title":"Mol Biol Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1399-0039.1998.tb03002.x","article-title":"Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in japanese","volume":"51","author":"Higuchi","year":"1998","journal-title":"Tissue Antigens."},{"key":"B49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0165-5728(96)00182-8","article-title":"TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients","volume":"72","author":"Huizinga","year":"1997","journal-title":"J Neuroimmunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/hmg\/11.11.1281","article-title":"inflammatory bowel disease is associated with a tnf polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors","volume":"11","author":"van Heel","year":"2002","journal-title":"Hum Mol Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1046\/j.1523-1747.2000.00001.x","article-title":"Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism","volume":"114","author":"Kaluza","year":"2000","journal-title":"J Invest Dermatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/1531-8249(200009)48:3<388::AID-ANA16>3.3.CO;2-7","article-title":"Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases alzheimer's disease risk","volume":"48","author":"Licastro","year":"2000","journal-title":"Ann Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"9159","DOI":"10.1007\/s13277-015-3593-x","article-title":"Influence of functional polymorphisms in TNF-alpha, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer","volume":"36","author":"de Oliveira","year":"2015","journal-title":"Tumour Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1440-1843.2012.02244.x","article-title":"AA genotype of IL-8\u2212251A\/T is associated with low PaO(2)\/FiO(2) in critically ill patients and with increased IL-8 expression","volume":"17","author":"Wacharasint","year":"2012","journal-title":"Respirology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/S0140-6736(17)30560-3","article-title":"Doxycycline vs. prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial","volume":"389","author":"Williams","year":"2017","journal-title":"Lancet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/bjd.16553","article-title":"Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced karnofsky score","volume":"179","author":"Holtsche","year":"2018","journal-title":"Br J Dermatol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00636\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T04:29:41Z","timestamp":1553833781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00636\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2019.00636"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00636","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]},"article-number":"636"}}